Persistent Short Sleep During Pregnancy Linked to Metabolic Syndrome
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 30, 2024 -- Short sleep duration that persists during pregnancy and for two to seven years after delivery is associated with increased odds of metabolic syndrome, according to a study published online Dec. 26 in JAMA Network Open.
Minjee Kim, M.D., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues examined whether persistently short sleep duration during pregnancy and after delivery is associated with incident hypertension and metabolic syndrome in a secondary analysis of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Heart Health Study. Participants were recruited during their first pregnancy between Oct. 1, 2010, and Sept. 30, 2013, and were followed for a mean of 3.1 years after delivery. Persistent short sleep was defined as self-reported short sleep duration (less than seven hours) during pregnancy and two to seven years after delivery.
Overall, 14.4 percent of the 3,922 participants experienced persistent short sleep. The researchers found that compared with non-Hispanic White and married participants, non-Hispanic Black and unmarried participants were significantly more likely to experience persistent short sleep (adjusted odds ratios [95 percent confidence intervals], 2.17 [1.59 to 2.97] and 1.68 [1.29 to 2.19], respectively). Higher odds of incident metabolic syndrome, but not incident hypertension, were seen in association with persistent short sleep (adjusted odds ratios [95 percent confidence intervals], 1.60 [1.2 to 2.11] and 0.91 [0.69 to 1.19], respectively).
"These findings highlight the need for targeted interventions aimed at improving sleep health among populations at increased risk to mitigate adverse health outcomes and to promote health equity," the authors write.
One author disclosed receiving grants from Genentech.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Trend Toward Survival Benefit Seen for REM-Inhibition in ALS
THURSDAY, May 22, 2025 -- For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a...
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
WEDNESDAY, May 21, 2025 -- Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do...
Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk
TUESDAY, May 20, 2025 -- Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.